These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33139813)

  • 41. OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chan SY; Wang Q; Wei WB; Jonas JB
    Retina; 2016 Nov; 36(11):2051-2058. PubMed ID: 27164548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative evaluation of choriocapillaris using optical coherence tomography and optical coherence tomography angiography in patients with central serous chorioretinopathy after half-dose photodynamic therapy.
    Yang HS; Kang TG; Park H; Heo JS; Park J; Lee KS; Choi S
    PLoS One; 2020; 15(1):e0227718. PubMed ID: 31929582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy.
    Kishi S; Matsumoto H; Sonoda S; Hiroe T; Sakamoto T; Akiyama H
    PLoS One; 2018; 13(11):e0206646. PubMed ID: 30412594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy.
    Yun C; Huh J; Ahn SM; Lee B; Kim JT; Hwang SY; Kim SW; Oh J
    Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):57-70. PubMed ID: 30397792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography.
    Nicolò M; Rosa R; Musetti D; Musolino M; Saccheggiani M; Traverso CE
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2002-2010. PubMed ID: 28384721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V; Vysloužilová D; Uher M
    Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment and Monitoring of Central Serous Chorioretinopathy in Pilots.
    Shinojima A; Mori R; Fujita K; Yuzawa M
    Aerosp Med Hum Perform; 2016 Dec; 87(12):1041-1044. PubMed ID: 28323591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
    Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
    Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classification of pachychoroid on optical coherence tomography using deep learning.
    Kang NY; Ra H; Lee K; Lee JH; Lee WK; Baek J
    Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):1803-1809. PubMed ID: 33616757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optical density ratio in the subretinal fluid: differentiating chronic central serous chorioretinopathy and polypodial choroidal vasculopathy.
    Baek J; Park YH
    Am J Ophthalmol; 2015 Feb; 159(2):386-92. PubMed ID: 25447112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CLASSIFICATION OF HALLER VESSEL ARRANGEMENTS IN ACUTE AND CHRONIC CENTRAL SEROUS CHORIORETINOPATHY IMAGED WITH EN FACE OPTICAL COHERENCE TOMOGRAPHY.
    Savastano MC; Dansingani KK; Rispoli M; Virgili G; Savastano A; Freund KB; Lumbroso B
    Retina; 2018 Jun; 38(6):1211-1215. PubMed ID: 28489695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [OCT-morphometric and angiographic parallels between different variants of central serous chorioretinopathy].
    Panova IE; Shaimov TB; Shaimova VA
    Vestn Oftalmol; 2017; 133(2):10-17. PubMed ID: 28524134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optical Coherence Tomography Angiography Quantitative Assessment of Choriocapillaris Blood Flow in Central Serous Chorioretinopathy.
    Rochepeau C; Kodjikian L; Garcia MA; Coulon C; Burillon C; Denis P; Delaunay B; Mathis T
    Am J Ophthalmol; 2018 Oct; 194():26-34. PubMed ID: 30053475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of features on SD-OCT between acute central serous chorioretinopathy and exudative age-related macular degeneration.
    Ahn SJ; Kim TW; Huh JW; Yu HG; Chung H
    Ophthalmic Surg Lasers Imaging; 2012; 43(5):374-82. PubMed ID: 22767337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optical coherence tomography features of acute central serous chorioretinopathy versus neovascular age-related macular degeneration.
    Cho M; Athanikar A; Paccione J; Wald KJ
    Br J Ophthalmol; 2010 May; 94(5):597-9. PubMed ID: 19822922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Morphologic changes in acute central serous chorioretinopathy evaluated by spectral domain optical coherence tomography].
    Yu H; Xia GY; Gao MH; Yu J; Zhang YY
    Zhonghua Yan Ke Za Zhi; 2011 Jun; 47(6):508-15. PubMed ID: 21914265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Sakamoto A; Tsujikawa A; Yamashiro K; Ojima Y; Yamada Y; Mukai H; Oshima S; Inoue T; Yoshimura N
    Ophthalmology; 2010 Sep; 117(9):1800-9, 1809.e1-2. PubMed ID: 20673590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Changes of choroidal thickness in central serous chorioretinopathy].
    Yang LH; Tian B; Shi XH; Ding N; Zhou D; Wei WB
    Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):874-7. PubMed ID: 23302239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Three-dimensional configuration of subretinal fluid in central serous chorioretinopathy.
    Ahn SE; Oh J; Oh JH; Oh IK; Kim SW; Huh K
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):5944-52. PubMed ID: 23920371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.